UCB

UCB.BR | EURONEXT | 0 Followers
€172.90 +1.53% €2.60
Follow
Overview Metrics Financials
Loading...

Fair Price

NBE554.32
Overvalued by 6.5%
To display the fair price of a share, you need to be a member of Bulios Black.

Profile

UCB SA (UCB) is a biopharmaceutical company based in Belgium, focusing on research, development, and production of medicinal products for the treatment of neurological and immunological disorders. The company specializes in medications for conditions such as epilepsy, Parkinson's disease, multiple sclerosis, and rheumatoid arthritis, among others. Their portfolio includes innovative drugs, biologic products, and prescription medications that improve the quality of life for patients suffering from these conditions. UCB also invests in research and development of new medications to provide effective and safe therapeutic options for patients worldwide. UCB SA (UCB) shares may be attractive to investors seeking investments in biopharmaceutical companies with an emphasis on innovation and treatment of neurological and immunological disorders.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios

Continue with Google
Continue with Apple
Continue with Facebook
Or use email and password
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
Menu StockBot
Tracker
Upgrade